D. Dana et al. / Tetrahedron Letters 54 (2013) 2717–2721
2721
7.86 (dd, J = 7.6 and 1.3 Hz, 2H). 13C NMR (100 MHz, (CDCl3)) d ppm: 36.8, 55.3,
114.3, 127.6, 128.1, 129.3, 129.9, 131.2, 133.3, 140.6, 145.9, 158.7. LRMS [ESI-
MS +ve] calcd for (C16H16O3S+Na): 311.1, observed: 311.0.
27. Bu, X. L.; Hong, L. C.; Liu, R. T.; Hong, J. Q.; Zhang, Z. X.; Zhou, X. G. Tetrahedron
2012, 68, 7960.
28. Castro, L. C. M.; Li, H. Q.; Sortais, J. B.; Darcel, C. Chem. Commun. 2012, 10514.
29. Kavanagh, S. A.; Piccinini, A.; Fleming, E. M.; Connon, S. J. Org. Biomol. Chem.
2008, 6, 1339.
30. Roberts, J. C.; Pincock, J. A. Can. J. Chem. 2003, 81, 709.
31. Chen, G. Q.; Xu, Z. J.; Zhou, C. Y.; Che, C. M. Chem. Commun. (Camb.) 2011,
10963.
32. All calculations were carried out in vacuum using SPARTAN program (Spartan ‘10,
version 1.1.0, Wavefunction Inc., Irvine, CA, 2011). The structures of the E and Z
isomers of 2, 9, 16, and 19 were minimized using MM2 calculations. The
minimized structures were then further subjected to DFT calculations using
B3LYP/6-311G⁄ basis set to obtain the equilibrium geometries and total
energies. From the energy-minimized structures of 2 and 16, one of the
methylene protons was removed to create the anion.
(Cinnamylsulfonyl)benzene (9). [see Table 1for 1H and 13C NMR assignments].
LRMS [ESI-MS +ve] calcd for (C15H14O2S+Na): 281.1, observed: 281.2.
(E)-4-(3-(Phenylsulfonyl)prop-1-en-1-yl)-1,10-biphenyl
(10).
1H
NMR
(500 MHz, (CD3)2CO) d ppm: 4.12 (d, J = 7.6 Hz, 2H), 6.22 (m, 1H), 6.53 (d,
J = 15.9 Hz, 1H), 7.32–7.51 (m, 5H), 7.59–7.77 (m, 7H), 7.92 (d, J = 7.4 Hz, 2H).
13C NMR (125 MHz, (CD3)2CO) d ppm: 59.66, 116.24, 126.69, 127.09, 127.10,
127.51, 128.37, 128.90, 129.14, 133.67, 135.32, 137.96, 139.30, 140.24, 140.77.
LRMS [ESI-MS +ve] calcd for (C21H18O2S+Na): 357.1, observed: 357.2.
(E)-1-(3-(Phenylsulfonyl)prop-1-en-1-yl)naphthalene (11). 1H NMR (400 MHz,
(CDCl3) d ppm: 4.09 (dd, J = 7.65, 1.0 Hz, 2H), 6.13 (m, 1H), 7.08 (d, J = 15.6 Hz,
1H), 7.38–7.96 (m, 12H). 13C NMR (100 MHz, (CDCl3)) d ppm: 60.69, 118.51,
123.50, 124.30, 125.57, 125.99, 126.26, 128.56, 128.68, 128.86, 129.21, 130.84,
133.46, 133.53, 133.80, 136.98, 138.28. LRMS [ESI-MS +ve] calcd for
(C19H16O2S+Na): 331.1, observed: 331.2.
33. Ohlinger, W. S.; Klunzinger, P. E.; Deppmeier, B. J.; Hehre, W. J. J. Phys. Chem. A
2009, 113, 2165.
34. Lee, P. S.; Du, W.; Boger, D. L.; Jorgensen, W. L. J. Org. Chem. 2004, 69, 5448.
35. Boutagy, J.; Thomas, R. Chem. Rev. 1974, 74, 87.
(E)-1-Methyl-2-(3-(phenylsulfonyl)prop-1-en-1-yl)benzene (12). 1H NMR
(500 MHz, (CDCl3)) d ppm: 2.13 (s, 3H), 3.98 (d, J = 7.6 Hz, 2H), 5.98 (dt,
J = 15.5, 7.6 Hz, 1H), 6.56 (d, J = 15.5 Hz, 1H), 7.10 (dd, J = 7.4, 2.0 Hz, 1H), 7.16
(td, J = 7.4, 2.0 Hz, 1H), 7.19 (td, J = 7.4, 2.0 Hz, 1H), 7.34 (dd, J = 7.4, 2.0 Hz, 1H),
7.54 (tt, J = 7.5, 1.3 Hz, 2H), 7.64 (tt, J = 7.5, 1.3 Hz, 1H), 7.90 (dd, J = 7.5, 1.3 Hz,
2H). 13C NMR (100 MHz, (CDCl3)) d ppm: 19.5, 60.7, 116.6, 125.9, 126.2, 128.4,
128.6, 129.1, 130.3, 133.8, 134.9, 135.6, 137.3, 138.4. LRMS [ESI-MS +ve] calcd
for (C16H16O2S+Na): 295.1, observed: 295.0.
36. Havens, S. J.; Hergenrother, P. M. J. Org. Chem. 1985, 50, 1763.
37. Lerebours, R.; Wolf, C. Org. Lett. 2007, 9, 2737.
38. (3-(Phenylsulfonyl)prop-1-ene-1,1-diyl)dibenzene (24) 1H NMR (500 MHz,
CDCl3)
d ppm: 3.93 (d, J = 7.9 Hz, 2H), 6.15 (t, J = 7.9 Hz, 1H), 6.67 (d,
J = 7.6 Hz, 2H), 7.16 (m, 2H), 7.23 (t, J = 7.6 Hz, 2H), 7.27 (m, 4H), 7.51 (t,
J = 7.6 Hz, 2H), 7.64 (t, J = 7.6 Hz, 1H), 7.80 (d, J = 7.6 Hz, 2H). 13C NMR
(100 MHz, CDCl3) d ppm: 57.5, 114.0, 127.4, 127.8, 128.2, 128.3, 128.4, 128.5,
129.1, 129.2, 133.7, 137.7, 138.5, 140.7, 149.7. LRMS [ESI-MS +ve] calcd for
(C21H18O2S+Na): 357.1, observed: 357.1.
(E)-1-Chloro-2-(3-(phenylsulfonyl)prop-1-en-1-yl)benzene (13). 1H NMR
(400 MHz, (CDCl3)) d ppm: 4.00 (d, J = 7.6 Hz, 2H), 6.12 (tt, J = 15.7, 7.6 Hz,
1H), 6.71 (d, J = 15.7 Hz, 1H), 7.21 (m, 2H), 7.31 (m, 1H), 7.46 (m, 1H), 7.55 (tt,
39. Yamamoto, Y.; Nisimura, T.; Nozaki, H. Bull. Chem. Soc. Jpn. 1971, 44, 541.
40. Farrugia, L. J. J. Appl. Crystallogr. 1997, 30, 565.
J = 7.4, 1.4 Hz, 2H), 7.65 (tt, J = 7.4, 1.4 Hz, 1H), 7.89 (dd, J = 7.4, 1.4 Hz, 2H). 13
C
NMR (100 MHz, CDCl3) d ppm: 60.5, 118.2, 127.0, 127.1, 128.5, 129.2, 129.5,
129.7, 133.2, 133.8, 133.9, 135.4, 138.2. LRMS [ESI-MS +ve] calcd for
(C15H13ClO2S+Na): 315.0, observed: 315.0.
41. (E)-(Pent-1-en-1-ylsulfonyl)benzene (16E). 1H NMR (500 MHz, CDCl3) d ppm:
0.92 (m, 3H), 1.50 (m, 2H), 2.23 (m, 2H), 6.33 (d, J = 15.0 Hz, 1H), 7.00 (m, 1H),
7.54 (m, 3H), 7.87 (m, 2H). 13C NMR (125 MHz, CDCl3) d ppm: 13.6, 20.9, 33.4,
127.5, 129.3, 130.4, 133.3, 140.7, 147.1. LRMS [ESI-MS +ve] calcd for
(C11H14O2S+Na): 233.1, observed: 233 (Z)-(pent-1-en-1-ylsulfonyl)benzene
(16Z). 1H NMR (500 MHz, CDCl3) d ppm: 0.92 (m, 3H), 1.50 (m, 2H), 2.64 (m,
2H), 6.33 (m, 2H), 7.54 (m, 3H), 7.92 (m, 2H). 13C NMR (125 MHz, CDCl3) d
ppm: 13.7, 21.9, 29.6, 127.2, 129.3, 130.5, 133.4, 141.8, 147.5. LRMS [ESI-MS
+ve] calcd for (C11H14O2S+Na): 233.1, observed: 233.2.
(E)-1-Methyl-4-(3-(phenylsulfonyl)prop-1-en-1-yl)benzene (14). 1H NMR
(400 MHz, CDCl3)
d ppm: 2.34 (s, 3H), 3.94 (d, J = 7.6 Hz, 2H), 6.05 (dt,
J = 15.6 and 7.6 Hz, 1H), 6.32 (d, J = 15.6 Hz and 1H) 7.11 (d, J = 8.0 Hz, 2H), 7.18
(d, J = 8.0 Hz, 2H), 7.53 (tt, J = 7.6 and 1.4 Hz, 2H), 7.63 (tt, 7.6 and 1.4 Hz, 1H),
7.88 (dd, J = 7.6 and 1.4 Hz, 2H). 13C NMR (100 MHz, (CDCl3)) d ppm: 21.3, 60.6,
114.0, 126.6, 128.6, 129.1, 129.4, 133.0, 133.7, 138.4, 138.6, 139.2. Calcd mass
for (C16H16O2S+Na): 295.1, observed: 295.0.
(E)-(Pent-2-en-1-ylsulfonyl)benzene (19E). 1H NMR (500 MHz, CD3OD) d ppm:
0.88 (t, J = 7.52 Hz, 3H), 1.98 (m, 2H), 3.87 (d, J = 7.31 Hz, 2H), 5.37(m, 1H),
5.56 (m, 1H), 7.71 (m, 2H), 7.71 (m, 1H), 7.86 (m, 2H). 13C NMR (125 MHz,
MeOD-D4) d ppm: 12.0, 25.2, 59.1, 115.2, 128.3, 128.8, 133.5, 138.3, 142.8.
LRMS [ESI-MS +ve] calcd for (C11H14O2S+Na): 233.1, observed: 233.2.
(Z)-(Pent-2-en-1-ylsulfonyl)benzene (19Z). 1H NMR (500 MHz, CD3OD) d ppm:
0.71 (t, J = 7.55 Hz, 3H), 1.77 (m, 2H), 3.98 (d, J = 8.01, 2H), 5.37 (m, 1H), 5.70
(m, 1H), 7.62 (m, 2H), 7.71 (m, 1H), 7.89 (m, 2H). 13C NMR (125 MHz,
MeOD-D4) d ppm: 12.3, 20.1, 54.2, 114.5, 128.2, 128.9, 133.6, 138.6, 140.7.
LRMS [ESI-MS +ve] calcd for (C11H14O2S+Na): 233.1, observed: 233.2.
42. Haynes, R. K.; Schober, P. A.; Binns, M. R. Aust. J. Chem. 1987, 40, 1223.
43. Wnuk, S. F.; Garcia, P. I.; Wang, Z. Z. Org. Lett. 2004, 6, 2047.
(E)-1-Methoxy-4-(3-(phenylsulfonyl)prop-1-en-1-yl)benzene (15). 1H NMR
(500 MHz, CDCl3)
d ppm: 3.81 (s, 3H), 3.93 (d, J = 7.7 Hz, 2H), 5.96 (tt,
J = 15.6, 7.7 Hz, 1H), 6.31 (d, J = 15.6 Hz, 1H), 6.84 (dd, J = 8.7 Hz, 2H), 7.23 (d,
J = 8.7 Hz, 2H), 7.54 (t, J = 7.7 Hz, 2H), 7.64 (t, J = 7.7 Hz, 1H), 7.88 (d, J = 7.7 Hz,
2H). 13C NMR (100 MHz, CDCl3) d ppm: 55.3, 60.6, 112.6, 114.1, 127.9, 128.5,
128.6, 129.1, 133.7, 138.5, 138.7, 159.9. LRMS [ESI-MS +ve] calcd for
(C16H16O3S+Na): 311.1, observed: 311.0.
23. Michrowska, A.; Bieniek, M.; Kim, M.; Klajn, R.; Grela, K. Tetrahedron 2003, 59,
4525.
24. Ettari, R.; Micale, N. J. Organomet. Chem. 2007, 692, 3574.
25. Cambridge Crystallographic Data Centre deposition No. 916842. The data can
be obtained free from Cambridge Crystallographic Data Centre via http://
44. Gais, H. J.; Babu, G. S.; Gunter, M.; Das, P. Eur. J. Org. Chem. 2004, 1464.
26. Grolla, A. A.; Podesta, V.; Chini, M. G.; Di Micco, S.; Vallario, A.; Genazzani, A. A.;
Canonico, P. L.; Bifulco, G.; Tron, G. C.; Sorba, G.; Pirali, T. J. Med. Chem. 2009, 52,
2776.